802 filings
ARS
2023 FY
VCEL
Vericel Corp
21 Mar 24
Annual report to shareholders
7:45am
DEFA14A
VCEL
Vericel Corp
21 Mar 24
Additional proxy soliciting materials
7:32am
DEF 14A
VCEL
Vericel Corp
Definitive proxy
21 Mar 24
7:30am
10-K
2023 FY
VCEL
Vericel Corp
Annual report
29 Feb 24
9:04am
8-K
VCEL
Vericel Corp
29 Feb 24
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
8:04am
8-K
oits226nmb
9 Jan 24
Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results
4:05pm
8-K
4v59sc
8 Nov 23
Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
8:06am
8-K
hipzc8l
20 Sep 23
Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults
4:31pm
8-K
s2rbicbiv
2 Aug 23
Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
8:03am
S-8
54otlo91bksx pyn8j
22 May 23
Registration of securities for employees
4:06pm
8-K
bhvvtefxuutut
10 May 23
Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
8:03am
8-K
fcyaelzj07yycj
5 May 23
Departure of Directors or Certain Officers
4:06pm
ARS
un61x12m
23 Mar 23
Annual report to shareholders
8:01am
DEFA14A
k4a5vex0tpu87
23 Mar 23
Additional proxy soliciting materials
8:01am
8-K
iislnfbs
23 Feb 23
Vericel Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Full-Year 2023 Financial Guidance
8:02am